IPO registrations (S-1, F-1) · Registrants
electroCore, Inc.
- SEC CIK
- 1560258 · filings on EDGAR ↗
- Former names
- ElectroCore, LLC (2012–2018)
- Registration
- Form S-1, first filed 2018-05-21, last 2024-07-18; 3 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2018-06-25; declared effective 2018-06-21
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 200 FORGE WAY, SUITE 205, Rockaway, NJ 07866
- EIN
- 20-3454976
- Ticker
- ECOR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- electroCore, Inc. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2018-06-11)
- Final price
- $15.00 per share, within the range (424B4 filed 2018-06-25, an initial public offering)
- Shares sold
- 5,200,000
- Gross proceeds
- $78,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ECOR
- Lead underwriters
- Evercore (2,158,000 shares); Cantor Fitzgerald (1,430,000 shares); JMP Securities (1,040,000 shares)
- Syndicate
- BTIG (572,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ELECTROCORE, INC. Fuzzy (name and state)
- Business registration: ELECTROCORE, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ELECTROCORE, INC. EXACT (EIN (EXACT))
- Federal award recipient: ELECTROCORE, INC. Fuzzy (name and state)
- Form D issuer: electroCore, Inc. EXACT (CIK (EXACT))
- Lobbying client: ELECTROCORE Fuzzy (name and state)
- Lobbying client: ELECTROCORE Fuzzy (name and state)
- SEC filer: electroCore, Inc. EXACT (CIK (EXACT))
- Person page: F Peter Cuneo Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Joseph P Errico Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Michael G Atieh Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2018-05-21 | S-1 | S-1 (registration) | ElectroCore, LLC | 0001193125-18-169701 ↗ |
| 2018-06-05 | S-1/A | S-1/A (amendment) | ElectroCore, LLC | 0001193125-18-184430 ↗ |
| 2018-06-11 | S-1/A | S-1/A (amendment) | ElectroCore, LLC | 0001193125-18-188631 ↗ |
| 2018-06-15 | S-1/A | S-1/A (amendment) | ElectroCore, LLC | 0001193125-18-194659 ↗ |
| 2018-06-21 | S-1MEF | S-1MEF (added securities) | electroCore, Inc. | 0001193125-18-199926 ↗ |
| 2018-06-21 | EFFECT | EFFECT (declared effective) | electroCore, Inc. | 9999999995-18-001571 ↗ |
| 2018-06-25 | 424B4 | 424B4 (final prospectus) | electroCore, Inc. | 0001193125-18-202346 ↗ |
| 2019-09-05 | EFFECT | EFFECT (declared effective) | electroCore, Inc. | 9999999995-19-002022 ↗ |
| 2020-06-02 | EFFECT | EFFECT (declared effective) | electroCore, Inc. | 9999999995-20-001320 ↗ |
| 2022-01-25 | EFFECT | EFFECT (declared effective) | electroCore, Inc. | 9999999995-22-000225 ↗ |
| 2023-08-24 | S-1 | S-1 (registration) | electroCore, Inc. | 0001193805-23-001213 ↗ |
| 2023-08-31 | EFFECT | EFFECT (declared effective) | electroCore, Inc. | 9999999995-23-002551 ↗ |
| 2024-07-10 | S-1 | S-1 (registration) | electroCore, Inc. | 0001193805-24-000900 ↗ |
| 2024-07-18 | S-1/A | S-1/A (amendment) | electroCore, Inc. | 0001193805-24-000942 ↗ |
| 2024-07-22 | EFFECT | EFFECT (declared effective) | electroCore, Inc. | 9999999995-24-002230 ↗ |
| 2025-07-24 | EFFECT | EFFECT (declared effective) | electroCore, Inc. | 9999999995-25-002339 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-06-11 | S-1/A | registration statement | $14.00–$16.00 | $15.00 | 4,333,333 | $64,999,995 | Nasdaq ECOR | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2018-06-15 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2018-06-25 | 424B4 | final prospectus | $15.00 | 5,200,000 | $78,000,000 | Nasdaq ECOR | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Amato Francis R. | Director,Officer | Chief Executive Officer | 4 | 2018–2019 | |
| ATIEH MICHAEL G | Director | 4 | 2018–2021 | person page Fuzzy | |
| Colucci Nicholas | Director | 2 | 2018–2019 | ||
| Core Ventures II, LLC | TenPercentOwner | 4 | 2018–2019 | ||
| COX CARRIE SMITH | Director | 5 | 2018–2019 | ||
| Errico Joseph P | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Science/Strategy Officer; See Remarks | 17 | 2018–2022 | person page Fuzzy |
| Errico Thomas J. | Director; Director,TenPercentOwner | 28 | 2018–2026 | ||
| Moody Trevor J | Director | 9 | 2018–2023 | ||
| Ondra Stephen | Director | 4 | 2018–2021 | ||
| Staats Peter S. | Officer | Chief Medical Officer | 3 | 2018–2019 | |
| TULLIS JAMES L L | Director | 6 | 2018–2020 | ||
| Vraniak Glenn S. | Officer | Chief Financial Officer | 2 | 2018–2019 | |
| Merck Global Health Innovation Fund, LLC | TenPercentOwner | 2 | 2018 | ||
| POSNER BRIAN M | Officer | Chief Financial Officer | 11 | 2019–2024 | |
| Goldberger Daniel S | Director,Officer; Other | Chief Executive Officer | 29 | 2019–2026 | |
| CUNEO F PETER | Director | 8 | 2020–2024 | person page Fuzzy | |
| GANDOLFO JOHN P | Director | 12 | 2020–2026 | ||
| PATTON THOMAS M | Director | 9 | 2020–2025 | ||
| Goldstein Julie Ann | Director | 9 | 2022–2026 | ||
| Wilber Patricia | Director | 7 | 2022–2026 | ||
| Theofilos Charles Steve | Director; Other | 5 | 2023–2025 | ||
| Lev Joshua S. | Officer | CFO and Interim President; Chief Financial Officer; See Remarks | 10 | 2024–2026 | |
| Theofilos James Charles | Director | 3 | 2025–2026 | ||
| Bonfiglioli Elena | Director | 3 | 2025–2026 | ||
| Fox Michael | Officer | Chief Operating Officer; See Remarks | 5 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-04-15 | electroCore, Inc. | Other Health Care | Indefinite | $0 | 0 | 1 |
| 2025-10-17 | electroCore, Inc. | Other Health Care | Indefinite | $0 | 0 | 1 |
| 2025-10-17 | electroCore, Inc. | Other Health Care | $1,856,000 | $1,856,000 | 3 | 1 |
| 2025-09-16 | electroCore, Inc. | Other Health Care | Indefinite | $0 | 0 | 1 |
| 2024-11-15 | electroCore, Inc. | Other Health Care | $0 | $0 | 0 | 1 |
| 2024-08-02 | electroCore, Inc. | Other Health Care | $0 | $0 | 0 | 1 |
| 2024-06-12 | electroCore, Inc. | Other Health Care | $7,845,000 | $7,845,000 | 13 | 1 |
| 2024-05-08 | electroCore, Inc. | Other Health Care | $0 | $0 | 0 | 1 |
| 2023-08-08 | electroCore, Inc. | Other Health Care | $52,372 | $52,372 | 7 | 1 |
| 2023-08-08 | electroCore, Inc. | Other Health Care | $750,000 | $750,000 | 6 | 1 |
| 2021-10-04 | electroCore, Inc. | Other Health Care | $192,000 | $192,000 | 0 | 1 |
| 2020-05-27 | electroCore, Inc. | Other Health Care | $1,548,701 | $1,548,701 | 1 | 1 |
| 2020-05-27 | electroCore, Inc. | Other Health Care | $463,678 | $463,678 | 1 | 1 |
| 2020-04-29 | electroCore, Inc. | Other Health Care | $1,749,999 | $1,749,999 | 3 | 1 |
| 2017-09-07 | ElectroCore, LLC | Other Health Care | $75,000,000 | $70,890,210 | 94 | 3 |
| 2016-08-05 | ElectroCore, LLC | Other Health Care | $8,000,000 | $1,500,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ELECTROCORE, INC. | NJ | State business registries | name and state |
| Business registration | ELECTROCORE, INC. | NJ | State business registries | name and state |
| Federal award recipient | ELECTROCORE, INC. | NJ | Federal spending (USAspending) | name and state |
| Form D issuer | electroCore, Inc. | NJ | Form D private offerings | CIK (EXACT) |
| Lobbying client | ELECTROCORE | NJ | Federal lobbying (LDA) | name and state |
| Lobbying client | ELECTROCORE | NJ | Federal lobbying (LDA) | name and state |
| Patent assignee | ElectroCore, Inc. | NJ | Patents (USPTO) | name and state |
| SEC filer | electroCore, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | ELECTROCORE, INC | NJ | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ELECTROCORE, INC. | EIN (EXACT) | ||
| Person page | F Peter Cuneo | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Joseph P Errico | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Michael G Atieh | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, NJ first:
- Echo Therapeutics, Inc. NJ
- Medifirst Solutions, Inc. NJ
- Origin Life Sciences, Inc. NJ
- Medisun Precision Medicine Ltd. 1T
- Solta Medical Corp A8
- ULTHERA INC AZ
- CardieX Ltd C3
- BeneChill, Inc. ca
- ENDOCARE INC CA
- IMAGYN MEDICAL INC CA
In other datasets, the same topic (Technology) in NJ:
- Form D issuer: A2Zlogix, Inc. (Form D private offerings)
- Lobbying client: 1KOSMOS INC (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology